Chemotherapy with anticancer drugs is known to be beneficial, but like a double-edged sword, it has its own demerits in the form of adverse effects. Cancer chemotherapy-induced thrombocytopenia is troublesome, and platinum-based regimens, namely carboplatin and cisplatin, are known to cause it very commonly. Gemcitabine, in combination with platinum compounds, is known to cause severe thrombocytopenia. Hence, we report a case of thrombocytopenia induced by gemcitabine when used as a single agent in the treatment of ovarian cancer.
|Number of pages||2|
|Journal||Asian Journal of Pharmaceutical and Clinical Research|
|Publication status||Published - 01-01-2017|
All Science Journal Classification (ASJC) codes
- Pharmaceutical Science
- Pharmacology (medical)